MedTrace Logo

A Trial for Patients With Gestational Trophoblastic Disease

NCT00190918 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2007-08-09

No results posted yet for this study

Summary

This phase II study is evaluating the activity of Pemetrexed in patients diagnosed with low risk Gestational Trophoblastic Tumor (GTT) that have failed prior treatment.

Conditions

  • Trophoblastic Neoplasms
  • Uterine Neoplasms
  • Hydatidiform Mole
  • Choriocarcinoma

Interventions

DRUG

Pemetrexed

Sponsors & Collaborators

Principal Investigators

  • David Miller, MD · Gynecologic Oncology Group

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Completion
2007-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00190918 on ClinicalTrials.gov